Table 1.
General profile of the patient population at the admission to the intensive care unit and outcome.
| Variable | Overall (n = 20) | Survivors (n = 8) | Nonsurvivors (n = 12) | p |
|---|---|---|---|---|
| Age (years) | 63.9 (56.3–71) | 59.6 (53.8–63.4 | 69.4 (63.6–72.3) | 0.037 |
| Gender male | 16 (80) | 7 (87.5) | 9 (75) | 0.619 |
| Weight (kg) | 90.5 (71.2–90) | 87.5 (81.2–102.5) | 77.5 (66.2–84) | 0.075 |
| Body mass index (kg/m2) | 26.5 (24.6–31.2) | 27.7 (26.3–33.5) | 25.4 (23.4-30) | 0.077 |
| Hypertension | 6 (30) | 2 (25) | 4 (33.3) | 0.690 |
| Diabetes | 5 (25) | 3 (37.5) | 2 (16.7) | 0.296 |
| Smoking history | 3 (15) | 2 (25) | 1 (8.3) | 0.537 |
| Heart disease | 3 (15) | 0 (0) | 3 (25) | 0.242 |
| Chronic lung disease | 2 (10) | 1 (12.5) | 1 (8.3) | 0.796 |
| e-GFR (mL/min/1.73 m2) | 101 (58–148) | 101 (45–137) | 105 (58–159) | 0.624 |
| Interleukin-6 (pg/mL) | 181 (40–338) | 126 (4–126) | 182 (43–467) | 0.398 |
| aPTT (s) | 35.6 (30.3–45.5) | 33.5 (28.8–59.8) | 38.3 (30.3-45.5) | 0.680 |
| Prothrombin activity (%) | 86 (78–92) | 87 (79–97) | 83 (64–91) | 0.432 |
| Antithrombin activity (%) | 91 (80–98) | 91 (81–100) | 91 (68-95) | 0.276 |
| Platelets (×1000 cells/μL) | 254 (148–295) | 237 (156–356) | 254 (128–295) | 0.939 |
| ICU length of stay (days) | 13.5 (8–32) | 25 (3.5–35) | 11.5 (8–17.2) | 0.699 |
| Pulmonary TE | 7 (35) | 0 (0) | 7 (58.3) | 0.015 |
| (documented at CT scan) | ||||
Data are median (interquartile range) or number (%). aPTT: activated partial thromboplastin time; CT: computerized tomography; eGFR: estimated glomerular filtration rate; ICU: intensive care unit; TE: thromboembolism.